MARKET WIRE NEWS

3 Reasons to Buy Green Thumb Industries Like There's No Tomorrow

Source: Motley Fool

2026-06-07 22:48:00 ET

The rescheduling of cannabis from a Schedule I to a Schedule III drug by the U.S. Department of Justice on April 23 means that the sector's stocks will no longer move in tandem with political winds. More than ever, there are cannabis winners and losers, and Green Thumb Industries (OTC: GTBIF) is among the former.

The company is financially strong enough, with self-sustaining cash generation, to benefit from recent regulatory changes and weather any short-term shifts.

The legal U.S. cannabis market was expected to be $137.7 bilion in 2026 and is expected to grow to a $1.43 trillion market by 2034, a compound annual growth rate of 34%, according to a Fortune Business Insights report.

Continue reading

Green Thumb Industries Inc (Sub Voting)

NASDAQ: GTBIF

GTBIF Trading

1.53% G/L:

$7.31 Last:

390,089 Volume:

$7.15 Open:

XXII Ad 300

GTBIF Latest News

$1,446,725,301
201,185,487
1.15%
9
N/A
Pharmaceuticals
Healthcare
US
Chicago

Check Your Online Brokerage For GTBIF

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App

Schedule a 30 minute Brand Awareness meeting with Market Wire News